1. Home
  2. MRCY vs TMDX Comparison

MRCY vs TMDX Comparison

Compare MRCY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercury Systems Inc

MRCY

Mercury Systems Inc

HOLD

Current Price

$70.52

Market Cap

4.6B

Sector

N/A

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$136.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRCY
TMDX
Founded
1981
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.9B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
MRCY
TMDX
Price
$70.52
$136.66
Analyst Decision
Buy
Buy
Analyst Count
7
10
Target Price
$76.43
$133.00
AVG Volume (30 Days)
596.2K
835.5K
Earning Date
11-04-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
170.70
EPS
N/A
2.54
Revenue
$932,798,000.00
$566,354,000.00
Revenue This Year
$6.17
$38.84
Revenue Next Year
$8.23
$20.43
P/E Ratio
N/A
$53.83
Revenue Growth
8.63
41.20
52 Week Low
$37.28
$55.00
52 Week High
$85.33
$156.00

Technical Indicators

Market Signals
Indicator
MRCY
TMDX
Relative Strength Index (RSI) 48.54 54.31
Support Level $66.58 $133.50
Resistance Level $72.22 $156.00
Average True Range (ATR) 2.55 8.50
MACD 0.45 0.41
Stochastic Oscillator 77.02 55.98

Price Performance

Historical Comparison
MRCY
TMDX

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: